|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. |
| 公司地址
| 6600 Dumbarton Circle, Fremont, CA, USA, 94555 |
| 電話號碼
| +1 650 752-1300 |
| 傳真號碼
| +1 650 752-1301 |
| 公司網頁
| https://www.personalis.com |
| 員工數量
| 260 |
| Mr. Aaron L. Tachibana |
Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer |
美元 545.90K |
02/04/2026 |
| Mr. Christopher Hall |
Director and Chief Executive Officer |
美元 618.00K |
17/03/2026 |
| Mr. Stephen M. Moore |
Senior Vice President, Chief Legal Officer and Corporate Secretary |
-- |
02/04/2026 |
| Dr. Richard Chen, M.D.,M.S. |
President, Executive Vice President, Research and Development and Chief Medical Officer |
美元 530.45K |
17/03/2026 |
|
|
| Mr. A. Blaine Bowman |
Independent Director |
02/04/2026 |
| Mr. Christopher Hall |
Director and Chief Executive Officer |
17/03/2026 |
| Ms. Karin Eastham |
Chairman of the Board |
02/04/2026 |
| Dr. Woodrow A. Myers, Jr,M.D. |
Independent Director |
02/04/2026 |
| Ms. Lonnie Shoff |
Independent Director |
02/04/2026 |
| Ms. Olivia K. Bloom |
Independent Director |
02/04/2026 |
| Dr. Kenneth J. Widder, M.D. |
Independent Director |
02/04/2026 |
|
|
|
|
